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Microglia serve in the surveillance and maintenance, protection and restoration of the
central nervous system (CNS) homeostasis. By their parenchymal location they differ from
other CNS-associated myeloid cells, and by origin as well as functional characteristics
they are also–at least in part–distinct from extraneural tissue macrophages. Nevertheless,
microglia themselves may not comprise a uniform cell type. CNS regions vary by cellular
and chemical composition, including white matter (myelin) content, blood–brain barrier
properties or prevailing neurotransmitters. Such a micromilieu could instruct as well
as require local adaptions of microglial features. Yet even cells within circumscribed
populations may reveal some specialization by subtypes, regarding house-keeping duties
and functional capacities upon challenges.While diversity of reactive phenotypes has been
established still little is known as towhether all activated cellswould respondwith the same
program of induced genes and functions or whether responder subsets have individual
contributions. Preferential synthesis of a key cytokine could asign a master control to
certain cells among a pool of activated microglia. Critical functions could be sequestered to
discretemicroglial subtypes in order to avoid interference, such as clearance of endogenous
material and presentation of antigens. Indeed, several and especially a number of recent
studies provide evidence for the constitutive and reactive heterogeneity of microglia by and
within CNS regions.While such a principle of “division of labor” would inﬂuence the basic
notion of “the” microglia, it could come with the practival value of addressing separate
microglia types in experimental and therapeutic manipulations.
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INTRODUCTION
Microglia are myeloid cells of the central nervous system (CNS).
They are found with parenchymal distribution throughout the
various regions of the brain, the spinal cord and also in the retina
where they engage with numerous tasks in the surveillance and
maintenance of the tissue homeostasis as well as the protection of
the structural and functional integrity of the CNS (Hanisch and
Kettenmann, 2007; Ransohoff and Cardona, 2010; Kettenmann
et al., 2011; Prinz et al., 2011; Saijo and Glass, 2011). We are cur-
rently vitnessing an enormous development in microglial research
as literally all aspects of their physiology undergo in-depth clariﬁ-
cation and revision. Was it for a long time a common believe that
microglia are under healthy conditions “resting” and function-
ally dormant it is now clear that they actively monitor their local
environment with motile processes, nurse synapses in periodical
interactions and assist in the myelin turnover by the clearance of
oligodenroglia-derived exosomes (Davalos et al., 2005; Nimmer-
jahn et al., 2005; Haynes et al., 2006; Wake et al., 2009; Graeber,
2010; Fitzner et al., 2011; Paolicelli et al., 2011; Tremblay et al.,
2011; Schafer et al., 2012; Kettenmann et al., 2013). Microglia
participate in the development and plasticity of the CNS (Saijo
and Glass, 2011; Tremblay et al., 2011; Kettenmann et al., 2013).
Fundamental questions concerning their developmental origin
and fate from embryonic states to aging, their turnover under
normal (healthy) and replenishment under disease conditions
have been addressed as well, employing sophisticated approaches
for unraveling lineage relations and principles of microglial in-
tissue maintenance (Mildner et al., 2007; Ginhoux et al., 2010;
Ajami et al., 2011; Schulz et al., 2012; Gomez Perdiguero et al.,
2013; Greter and Merad, 2013; Kierdorf et al., 2013; Yona et al.,
2013). Most notably, features and functions as sentinels and
innate immune cell are of foremost interest as they regard cru-
cial roles played by microglia in emergency situations and chronic
diseases.
Their striking ability to rapidly react to infection, trauma,
ischemia or other real or potential threats has been known as
microglial “activation”. However, this term does not adequately
reﬂect the diversity of response options, nor does it deﬁne the
net impact on the CNS (Hanisch and Kettenmann, 2007; Ket-
tenmann et al., 2011; Hanisch, 2012). Against earlier notions that
dominated the text book knowledge for a long time, microglia
are not notorious miscreants lurking in the CNS to harm neu-
rons on any occasion. They are not placed there simply as a
risk factor. Their association with a lesion does not automati-
cally identify them as a harming component, and even proven
involvement in neuropathologic events and processes might be
outnumbered by the cases in which their activity limits the dam-
age or eliminates a localized minor defect. However, most of their
protective actions probably remain unnoticed, while our view on
pathological implications got biased for situations in which such
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activities failed (Schwartz et al., 2006; Hanisch and Kettenmann,
2007). On the other hand, harmful contributions of microglia have
been convincingly demonstrated, indicating that the actual impact
can differ dramatically. Indeed, eligibility for diverse responses
and complexity of the functional repertoire are key elements in
microglial physiology.
The concept of reactive phenotypes, originally and largely
founded by investigations on extraneural macrophages, has mean-
while been expanded to microglia (Mantovani et al., 2004; Town
et al., 2005; Butovsky et al., 2006c; Schwartz et al., 2006; Hanisch
and Kettenmann, 2007; Mosser and Edwards, 2008; Ransohoff
and Perry, 2009; David and Kroner, 2011; Olah et al., 2011). It
encompasses the recognition of a plethora of “activating” sig-
nals, their integration in the context of a given situation and their
translation into adapted proﬁles of induced (or suppressed) genes
and functions (Gordon and Taylor, 2005; Mosser and Edwards,
2008; Murray and Wynn, 2011; Hanisch, 2012, 2013). It also
allows to better understand at the molecular, cellular and sys-
temic level why and how microglial activation can result in rather
protective outcomes or in a worsening of the damage. Proper
selection and initiation, maturation and termination of reactive
phenotypes are essential not only for the immediate responses
to acute insults. They are immanent to the development and
progression of autoimmune, neurodegenerative and age-related
diseases, primary tumors and metastases, certain neuropsychiatric
disorders as well as the compensatory and restorative attempts
of the CNS (Miller and Streit, 2007; Perry et al., 2007; Monji
et al., 2009; Pollard, 2009; Neumann et al., 2009; Chen et al.,
2010; Prinz et al., 2011; Derecki et al., 2012; Cunningham, 2013;
Aguzzi et al., 2013).
A question not yet addressed properly concerns the simple
reﬂection as to whether the large number of microglia in a CNS
represents a homogeneous population with identical duties and
functional capacities. Microglia can account for 5–12% of the
cell numbers, depending on the anatomical region (Lawson et al.,
1990). These regions differ by biochemical and cellular composi-
tion, circuitry and functions – and thus probably differ by their
needs of support and assistance. Diversity in morphology, phys-
iology and even aspects of immunity is established or getting
more and more recognized for subtypes of neurons and astro-
cytes (Landgraf and Evers, 2005; Matyash and Kettenmann, 2010;
Cho et al., 2013). Immune cells, such as lymphocytes, dendritic
and also monocytic cells are classiﬁed by subsets that diversify by
expression patterns and functions (Yona and Jung, 2010; Satpathy
et al., 2012). Microglia, however, the principal immunocompe-
tent element of the CNS, would still be considered as a uniform
community with standardized properties, just varying by regional
density, obscure cell shape parameters or some protein expression
levels? This is rather unlikely. It appears especially doubtful in
the light of evidence for constitutive heterogeneity and responder
diversity.
While this idea still awaits more experimental validation as
well as conceptual maturation, ﬁrst ﬁndings and interpretations,
implications and consequences have been presented and discussed
previously already (Hanisch and Kettenmann, 2007; Hanisch,
2012, 2013), and essentials as well as new elements will be stressed
below. They concern a principle by which some microglia can
act as a master subset due to a privileged release of a cytokine,
such as tumor necrosis factor α (TNFα). Such a cell may take
the role of a primus inter pares within a local community to gov-
ern activities of neighboring cells (Figure 1). They also address
the preferential expression of major histocompatibility complex
(MHC) structures for antigen presentation and of a molecular
machinery that would allow a discrete routing of phagocytotic
cargo to subsets of microglia. Organized in distinct subpopu-
lations potentially interfering functions could thereby segregate.
Notably, the reactive phenotypes with their proﬁles of transcribed
genes and executed functions couldbuildupon the individual con-
tributions of responding sets of microglia, rather than representing
the mere sum of equal performances. Nevertheless, whether and
how such specialized capacities are pre-determined or randomly
assigned to subsets among a population of reactivemicroglia is not
known yet.
HETEROGENEITY OF TISSUE MACROPHAGES
Macrophages are found in many tissues and organs. They share
a core of duties for which they are equipped with an array of
constitutively expressed or inducible molecules, such as recep-
tors, enzymes, or cytokines. While macrophage-associated tasks in
homeostatic control or responses to damage and infection obvi-
ously rely on similar sets of genes and functions the various tissue
environments must also determine adaptations of features. Kupf-
fer cells in the liver, alveolarmacrophages in the lung, osteoclasts in
the bones or the macrophages in the spleen are embedded within
characteristic cellular communities and are exposed to particu-
lar bio/chemical milieus. Accordingly, gene expression patterns
and the organization of functions under normal conditions and
in emergency situations likely require adjustment and control to
suite the particular needs. Indeed, sophisticated analyses reveal a
substantial diversity in the transcriptomes of tissue macrophages
(Gautier et al., 2012) as well as in the factors that guide their
development (Greter and Merad, 2013).
MACROPHAGES AS A FAMILY OF MYELOID CELLS
An assessment of the gene expression proﬁles in resting peritoneal,
pulp splenic and lung macrophages as well as CNS microglia
revealed a considerable degree of diversity between these popu-
lations, more than among populations of dendritic cells (DCs)
studied in parallel (Gautier et al., 2012). Several genes distin-
guished macrophages from DCs. They comprised a signature that
was more or less deﬁnite depending on the criteria of strict exclu-
siveness, levels of expression or presence in all or only some of
the macrophage types. It included the immunoglobulin Fc recep-
tors FcγRI (CD64) and FcγRIII (CD16), Toll-like receptor (TLR)
4 and its coreceptor CD14, the receptor of granulocyte colony
stimulating factor (G-CSF), the MHC class I-related molecule
MR1 and some enzymes with metabolic implications or (other)
roles in signaling. Molecules commonly serving detection of (tis-
sue) macrophages – besides F4/80 as the prototypical marker-,
such as CD11b (αM integrin, complement receptor 3 CR3),
CD68 (macrosialin), or CD206 (mannose receptor), did not ful-
ﬁll the demanding properties of exclusive and/or panpopulational
expression by macrophages (Gautier et al., 2012).
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FIGURE 1 | Schematic overview of the conceptual framework and
some supporting findings pointing to a heterogeneity of microglial
properties. (A) In the normal CNS tissues, microglia comprise a population
of myeloid cells with parenchymal distribution. The ramiﬁed morphology
and a low expression of immune function-related molecules
(Continued)
FIGURE 1 | Continued
were formerly taken as signs of a “resting” status. This view got corrected
upon demonstration of active tissue surveillance and periodic inspection of
synapses with their motile processes. Nevertheless, by morphology and
immunophenotype, microglia may still largely appear as a homogeneous
cell type, although regional differences exist regarding density, morphology,
capacity for proliferation and expression of certain proteins (or antigenic
structures). On the other hand, subtle or yet unidentiﬁed variations in
house-keeping duties (such as the nursing of synapses) and latent
capacities may exist that deﬁne subtypes among and within anatomical
subdivisions. (B) One of the duties unequally performed by microglia under
physiological conditions relates to the macropinocytotic uptake of
myelin-laden exosomes as they are emitted by oligodendrocytes in a
principle of “outsourced” myelin turnover. Upon a challenge, such as by
IFNγ, this subset of microglia reveals a lack of MHC II expression, in
opposition to a largely complementary portion of cells that readily
upregulate the surface structure for (potential) professional antigen
presentation – but, in turn, do not engage with the exosomal clearance. As
a purpose of this division of labor, immunologically silent disposal of
endogenous material can take place in a sequestered compartment. (C)
Challenges by bacterial agents, like LPS, or probably also appearance of
endogenous factors with a connotation of damage and a similar
TLR4-agonistic activity, can induce the synthesis of TNFα, which can then
affect the vitality and functionality of resident as well as inﬁltrating
(immune) cells. Since the production appears to be a privilege of some
microglia only (even within local cell communities), they could claim the role
of an instructor role or maître de plaisir during a response. TNFα-producing
cells further subdivide by the ability or inability to also release CCL3. Yet the
organization of such responder subtypes could be based on entirely
different principles. Cellular subsets could be predetermined as to their
functional capacities, acquire such distinction by environmental cues or
regulate activities in a stochastic process. The scheme was adapted from
previous own work (Hanisch and Kettenmann, 2007; Scheffel et al., 2012).
DIVERSITY AMONG THE MACROPHAGES FROM DIFFERENT
TISSUES
Macrophage populations also differ themselves by numerous
molecules that they can express. TLRs, C-type lectins as well
as chemokine and efferocytic receptors were identiﬁed as gene
families with heterogeneous expression patterns, thus point-
ing to tissue-speciﬁc adjustments in typical innate immune and
macrophage effector activities (Gautier et al., 2012). Other studies
on the relatedness of microglia to myeloid cells in particular as
well as to immune and non-immune cells in general concluded
on a strong similarity to the bone marrow-derived macrophages
(BMDM), more than to peritoneal macrophages (Saijo and Glass,
2011). In our own work, when comparing the organization and
properties of TLR-stimulated responses, we also see more simi-
larities of microglia to BMDM than to peritoneal macrophages,
suggesting that relationships are reﬂected by the reactive behav-
ior as well. Tissue macrophages may thus vary by molecular
equipment due to functional requirements as well as the daily or
situational exposure to different signals (Davoust et al., 2008; Mur-
ray and Wynn, 2011; Hanisch, 2012). While alveolar macrophages
are continuously confronted by airborne microbes, their peri-
toneal counterparts may occasionally sense traces of agents that
derive from commensal microbiota. Microglia, on the contrary,
would normally never face confrontations with such factors. Their
appearance must then be interpreted as a true threat.
Cluster analyses of gene proﬁles, protein expression or func-
tional activities inmyeloid cellsmight be less affected by themouse
strain or even the species of the laboratory animals, as long as cell
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types are compared within each category and assuming that such
fundamental relationships are conserved. Nevertheless, system-
atic comparisons of the mouse and human cell repertoire are still
lacking to ensure that classiﬁcations relying on animals studies
are representative. Comparisons of the molecular and functional
features are certainly prone to pitfalls when routine preparations
of cells involve animals of different ages. Cultures of microglia
served in a countless number of studies and delivered invaluable
information on their basic properties (Kettenmann et al., 2011).
Yet the popular standard in vitro setting uses newborn mice and
rats, whereas peritoneal macrophages, for example, are more eas-
ily isolated from (young) adults. Differences deliberately assigned
to the tissue may thus rather be determined by the ontogenetic
stage.
Indeed, microglial cells reveal a remarkable maturation of
basic features and response options during postnatal development
(Scheffel et al., 2012). Moreover, if a property is well established
for these cells, then it is the ability to rapidly react to even subtle
changes in their environment as brought about by cellular impair-
ments, blood–brain barrier (BBB) disruption and tissue injury
(Hanisch and Kettenmann, 2007). Any preparational procedure
that would result in a liberation of microglia-active substances
and would allow them to exert inﬂuences on gene regulation at the
time point of sampling may suffer from confounding responses to
damage. Evenmild cell isolations unavoidably associate with tissue
disintegration. This has been stimulating efforts to develop appro-
priate techniques by wich undesired stimulation of microglia is
largely circumvented or excluded from affecting the actual status
of the cells at the time point of their isolation (Mertsch et al., 2001;
de Haas et al., 2008). As an alternative, isolation and characteri-
zation can be separated in time, to allow accommodation of the
cells. Such a strategy bears the risk that features acquired by cells –
and in particular microglia – in the intact tissue at a given time,
location and state are lost upon sampling and passing through
cultivation. Surprisingly, however, critical properties can still be
preserved. Analyses of molecular and physiological properties of
microglia ex vivo under basal and stimulated conditions revealed
a developmental proﬁle, with gradual and transient adjustments
according to the animal age at cell isolation, rather than as a func-
tion of time in culture (Scheffel et al., 2012). Apparently, cells can
maintain a status (or critical aspects of) relating to the situation
in vivo.
MICROGLIA AS A CNS-SPECIFIC POPULATION OF MYELOID CELLS
Microglia comprise myeloid cells with parenchymal distribu-
tion. They thereby differ by location from other cells of the
mononuclear phagocyte system that are containedwithin the bony
compartment harboring the CNS, such as the perivascular cells or
the macrophages of the choroid plexus and the meninges (Ket-
tenmann et al., 2011). The ﬁne processes that can be visualized
by antibody and lectin staining for marker molecules or that
are revealed in transgenic animals expressing ﬂuorescent proteins
under the control of (more or less) microglia-selective promotors
(Kettenmann et al., 2011) were commonly taken as an indication
of a “resting” state. As meanwhile known better, this ramiﬁed
morphology is a cytoarchitectural reﬂection of their surveillance
function in the healthy adult tissue (Nimmerjahn et al., 2005). By
territorial organization and with a cell body staying faithful to the
location, the processes are in constant motion to sample infor-
mation about the homeostatic situation, to receive inputs about
the activity of nearby neurons (and other glia) and to scan the
synaptic interconnections. It is probably a ﬁne-anatomical adap-
tation to the complex tissue organization that enables microglia
to reach with their tiny arms into narrow spaces between axons
and dendritic trees without disturbing their structure and func-
tionality. Besides a surveillance, it guarantees precision in shaping
neuronal connections, as a suggested role of microglia in CNS
development and plasticity as well as in response to altered
neuronal activity. The phenomenon, termed synaptic stripping
or pruning, has been elegantly shown by a number of stud-
ies (Wake et al., 2009; Paolicelli et al., 2011; Schafer et al., 2012;
Kettenmann et al., 2013).
The delicate CNS architecture also determines that innate
immune reactions of microglia are tightly controlled. The proin-
ﬂammatory response repertoire is essential for ﬁghting infections,
but it also contributes – with many facets – to the events follow-
ing tissue damage, non-infectious injuries as well as subsequent
attempts of repair, while carrying enormous potential for aggra-
vating destructive cascades (Bitsch et al., 2000; Butovsky et al.,
2006b; Schwartz et al., 2006; Block et al., 2007; Chen and Nunez,
2010). Uncontrolled inﬂammation and tissue swelling are not tol-
erated by the CNS. Upon such disturbances and insults, microglia
depart from the surveillance mode and activate programs for
executive actions that must be kept in magnitude and organized
by quality to serve as much in the defense as simultaneously
avoiding unnecessary impairment (Hanisch and Kettenmann,
2007; Kettenmann et al., 2011). Along with a functional transi-
tion, microglial processes are rapidly reorientated, the ramiﬁed
morphology resolves, cells turn into a more ameboid shape and
even migrate to the site of a lesion. This remarkable change has
been taken as a prototypical sign of a microgial response, and
it was noted already at the dawn of microglia research (Ketten-
mann et al., 2011). Nevertheless, whereas morphology changes
with and in support of function, and often also with complex
spatiotemporal pattern (Morrison and Filosa, 2013), it is not
automatically a reliable surrogate of the actual activities (Ilschner
and Brandt, 1996). On the other hand, variations in the cel-
lular shape, as seen in the various anatomical divisions, may
still point to adjustments to the environment. When consider-
ing heterogeneity of microglia, these adjustments should not be
ignored.
While the BBB guarantees a special milieu in terms of the
ionic, molecular and cellular CNS composition it is not an impen-
etrable wall, but rather an interface and check point where a
controlled exchange of nutrients and metabolites is managed.
Also for the so-called “immune privilege” of the CNS, its roles
and mechanisms in immune surveillance and the organization
of immune reactions are now better understood as to their
anatomical fundaments as well as physiological processes (Bech-
mann et al., 2007; Ransohoff and Engelhardt, 2012). The BBB
yet also differs in organizational features throughout the CNS
and can change by integrity and functional properties which, in
turn, can affect local populations of microglia. In other words,
the CNS and its vascular (and also ependymal) lining create a
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special compartment in which microglia are embedded. Suited
for the neuronal functions, this milieu instructs and requires
also the functions of microglia. They may vary as vascular and
other anatomical properties differ throughout space. Neverthe-
less, local variations are likely also imposed by intrinsic, namely
cellular, elements of the tissue regions, as stressed below. Most
essentially, microglia may after all identify themselves as being
(i) distinct from extraneural tissue macrophages, (ii) and dis-
tinct from other CNS-associated myeloid cell populations as
well as (iii) representing a blend with closely related pheno-
types but still discrete functional capacities (Carson et al., 2007;
Hanisch and Kettenmann, 2007).
HETEROGENEITY OF MICROGLIAL RESPONSES AND
RESPONDERS
While the concept of monocyte/macrophage diversity due to ori-
gin and location has a longer history (Treves, 1984; Naito et al.,
1996; Sunderkotter et al., 2004), a conscious transfer to microglia
could now take ground aswell. More andmore studies also address
microglia in the aging brain, variations by species and gender
or the surprising differences among individuals (Mouton et al.,
2002; Meeuwsen et al., 2005; Sierra et al., 2007; Streit et al., 2008).
Analyses of this kind may need to deal with a sophisticated char-
acterization of microglial properties at close inspection and even
at the single-cell level.
CONSTITUTIVE HETEROGENEITY BY PROTEIN EXPRESSION
In contrast to the morphology, expression of proteins suited
for the identiﬁcation of microglia among neural cells (i.e.,
neurons, astrocytes, oligodendrocytes) is not equally selective
when distinguishing microglia from other myeloid cells. Certain
molecules (namely proteins and carbohydrates) allow the visual-
ization of microglia in animal and human tissues as well as cell
cultures although their physiological functions and sometimes
even the exact nature are largely unknown. This concerns, for
example, moieties bound by certain lectins. Other molecules are
characterized as receptors, adhesion molecules or as an intra-
cellular calcium-binding factor, including CD11b/CD18 (αMβ2
integrin, CR3, MAC1) or Iba1 (Kettenmann et al., 2011; Prinz
et al., 2011; Greter and Merad, 2013). CD16/32/64 (FcγRIII/II/I),
CD45 (leukocyte common antigen, LCA), CD68 (macrosialin),
CD115 (CSF1R), CD163 (scavenger receptor, ED2), CD169
(sialoadhesin, siglec 1), CD204 (MSR), CD206 (mannose recep-
tor), dectin-1 (β-glucan receptor), and F4/80 have been serving
in the detection of microglia, although levels of expression
vary (mostly increase) with or even depend on activating chal-
lenges, thus potentially biasing detection for activity states
(Kettenmann et al., 2011).
Due to shared expression, most of them would not allow an
unequivocal identiﬁcation of microglial cells when monocytic
inﬁltrates intermingle with them in a lesion, especially when
also the microglial morphology is altered. Factors, like CD45,
still discriminate microglia from perivascular and peripheral cells
since expression is low(er) and can thus serve discrimination
especially in ﬂow cytometry. Other proteins are suggested to
identify circulating and recently invadedmonocytes/macrophages,
like macrophage-related proteins (MRPs) 8 and 14 (S100A8 and
S100A9), whereas again others fail to be unique to microglia or
have limited value for certain species (Kettenmann et al., 2011).
Accordingly, combinations of two or more markers are more
practicable or even required, depending on the study and the
biological material. The discriminating potential of newly iden-
tiﬁed genes with selective expression in microglia still needs
conﬁrmation, but could offer additional options (Donnou et al.,
2005). Inside the CNS, expression of CX3CR1, the receptor of the
chemokine CX3CL1 (fractalkine), is restricted to microglia (and
other brain macrophages). In turn, CCR2 as the receptor for the
monocyte-attracting chemokine CCL2 (MCP-1) is expressed by
cells in the blood stream, but under non-inﬂammatory condi-
tions not found within the CNS – a patho/physiological relevant
pattern that has been technically extremely useful (Mildner et al.,
2007; Saederup et al., 2010; Prinz et al., 2011; Tremblay et al.,
2011; Mizutani et al., 2012). The availability of transgenic animals
with ﬂuorescent reporter proteins has thus tremendously fostered
studies on the rate and impact of monocytic inﬁltration of the
CNS.
Several of the above listed as well as additional molecules
representing surface receptors, cytokines and trophic factors or
enzymes reveal inhomogeneous expression by microglia, at least
in terms of detectable presence at mRNA and protein level
or signaling organization. A short list has been compiled in
recent reviews and includes CD11c, CD34, CD40, CD45, CD86,
CXCL14, FcγRII, IGF-I, IL-6, inducible nitric oxide synthase
(iNOS), certains integrins, MHC II, neurotrophins, Tim-3, TNFα,
Trem-2 as well as ion channels (Kettenmann et al., 2011; Hanisch,
2012, 2013).
One has to acknowledge that consciously presented and inter-
preted evidence for heterogeneity among microglia in terms of
selective or preferential expressions of a molecular structure can
be found in the literature records of more than a decade ago
(Rezaie and Male, 1999). Even though respective glyo/protein(s)
had occasionally unidentiﬁed functions such work pointed to the
uniqueness of microglia in the myelomonocytic lineage and doc-
umented variations among microglia. In rat brain and spinal
cord, two cell populations were identiﬁed by the expression of
the 5D4 keratan sulfate (KS) epitope. Occurring as of postna-
tal week 21, KS associated exclusively with ramiﬁed, but not
with (activated) ameboid microglia (Wilms et al., 1999). It was
found to be absent from other CNS macrophages (namely in
the choroid plexus, vessel walls or meninges). Also peripheral
monocytes/macrophages lacked its expression. KS+ microglia dis-
tributed ubiquitously, but not uniformly throughout the CNS.
Expressing cells were enriched in some regions and almost absent
in others. These cells prefered gray over white matter as location
and the global pattern suggested a favor of tissues with neuroge-
nesis potential. The partially intimate contact to neurons pointed
to a nursing function. Like for the in situ investigation, KS+
microglia comprised a subset in vitro, among cells expressing the
CR3 or ED1 epitope without being affected by lipopolysaccharide
(LPS) or interferon-γ (IFNγ) stimulations. Thus, while certain
molecules (or at least epitopes) reveal amore or less pan-microglial
or even general macrophage expression under basal and/or acti-
vated conditions (e.g., CR3, or in one of our studies MHC I
as shown below), others can apparently discriminate microglial
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subpopulations by discrete anatomical distribution, white versus
gray matter association and timed or transient appearance dur-
ing ontogeny. Notably, subtypes can occur within a circumscribed
region.
One of the most systematic studies thus far could determine
regional expression proﬁles based on ex vivo ﬂow cytometric anal-
ysis of CD11b,CD40,CD45,CD80,CD86, F4/80,TREM-2b,MHC
II, CXCR3, CCR7, and CCR9 in isolated microglia (de Haas et al.,
2008). Another study from this group related the CXCL10/CXCR3
system to the differential involvement of the localmicroglia in exci-
totoxic actions on neurons in in the mouse hippocampal regions
CA1 and CA3, as triggered by N-methyl-D-aspartic acid (NMDA)
administration (van Weering et al., 2010). This demonstration
goes beyond mere detection of expression levels by identifying
functional implications of a ligand-receptor signaling inmicroglia,
by presenting a consequence for the neuronal environment as
well as by showing the distinguished microglial impact for tissue
regions in close vicinity. Expression and activity features would
therefore not only vary between gross-anatomical structures but
even within short ranges.
Going even further by the niveau of local resolution, microglial
cells in side-by-side position could be shown to dissociate as to
an altered protein expression – indicating a split in their individ-
ual duties. The triggering receptor expressed on myeloid cells-2
(Trem-2) is expressed by microglia under normal conditions
and down-regulated when the cells are challenged. Such chal-
lenges can be achieved with LPS, a major cell wall constituent of
Gram-negative bacteria signaling through TLR4, or with IFNγ,
the immune IFN produced by natural killer (NK) cells and T
cells of the Th1 type (Schmid et al., 2002). Both factors can
drive a microglial phenotype that is well-known from studies
on macrophages and has been termed as classical (also M1) or
innate activation, as discussed below (Gordon and Taylor, 2005;
Hanisch and Kettenmann, 2007; Mosser and Edwards, 2008). As
a receptor with relevance for microglia and phagocytosis, Trem-
2 is in the focus of research on autoimmune, neurodegenerative
and (neuro)inﬂammatory diseases, including multiple sclerosis
and Morbus Alzheimer (Piccio et al., 2008; Neumann and Daly,
2013). Besides other proteins, Trem-2 expression may also give
hints to a heterogenous organization of microglia (Schmid et al.,
2009). Not all microglia do express Trem-2 and this distinction is
seen between as well as within CNS regions (Schmid et al., 2002).
Interestingly, microglia in areas with incomplete BBB exhibited
lowest expression. It is also interesting to speculate that plasma
factors probably sensed by such a microglia are responsible for the
reduced expression. Indeed, the plasma contains factors that can
signal via TLR4 and that install in microglia a response that is in
part similar to the reactive phenotype induced by LPS (Regen et al.,
2011; Hanisch, 2013). Intriguingly, microglial cells in immediate
vicinity to each other were reported to clearly differ by Trem-2
expression (Schmid et al., 2002). This is a conscious notion of
intralocational distinction by protein expression – published a
decade ago. In other studies, such information can likely be con-
tained in the datawithout an explicit interpretation. Along this line
and with conscious conclusion, microglia subtypes were recently
described with regard to myelin removal under both physiolog-
ical and pathophysiological conditions (van Rossum et al., 2008;
Fitzner et al., 2011; Regen et al., 2011; Scheffel et al., 2012). More-
over, also TLR4- or IFNγ receptor-driven responses by cytokine
release and expression of other surface molecules unraveled the
existence of responder subtypes (Scheffel et al., 2012).
HETEROGENEITY IN HOUSE-KEEPING FUNCTIONS
The never-resting microglia seem to cover also a particular func-
tion in the normal turnover of myelin (Fitzner et al., 2011).
Oligodendrocytes create the extremely well-organized and also
tremendously elaborate myelin structures that require constant
upkeep. Apparently, they thereby rely on the assistance of
microglia. Oligodendrocytes can wrap myelin material from their
turnover process in exosomes and deliver them to the microglia in
their surrounding. The principle of outsourcing has been recently
described, both in vitro and in vivo, and involves a subpopula-
tion of microglia for clearance (Fitzner et al., 2011). Microglia
taking up these myelin-laden exosomes would not upregulate
MHC II when, for example, being stimulated by IFNγ. The
assumption that this group of microglia would then also not
function as antigen-presenting cells got conﬁrmed in respective
T cell activation assays. The exosome uptake, that is carried
out by macropinocytosis, does otherwise not trigger concomi-
tant responses, such as release of proinﬂammatory mediators,
nor does it lead to overt signs of “activation” within the tissue.
On the other hand, challenges by inﬂammatory stimuli, such as
IFNγ and LPS, led to a decrease in exosome internalization. In
turn, those microglial cells increasing MHC II levels upon IFNγ
treatment were obviously devoid of exosomal clearing activity.
As a conclusion, we formulated the hypothesis of an immuno-
logically silent disposal of endogenous material (Fitzner et al.,
2011). As a service for oligodendrocytes, myelin would be con-
stantly routed to a specialized cellular compartment, i.e., a pool of
microglia, from which it could not be “accidentally” presented to
the adaptive immunity. One may speculate that a disturbance in
this segregation could be detrimental, and there might be actual
links to the triggering of myelin-afﬂicting autoimmune diseases,
such as multiple sclerosis. Such a daily function in the turnover of
self-derived material would be distinct from and exceed phagocy-
totic removal of aberrant cells and structures during development
(Schlegelmilch et al., 2011).
The necessity of such microglial functions during development
as well as later on is further illustrated by the impact of dysfunc-
tional microglia on higher CNS functions. In an animal model
of the human obsessive-compulsive disorder spectrum, microglia
with a mutation in Hoxb8 associate with behavioral symptoms
of compulsive grooming and hair removal (Chen et al., 2010).
Microglia with a MECP2 gene mutation and showing insufﬁ-
cient phagocytotic performance were characterized as a cellular
substrate of pathology in a mouse model of Rett syndrome,
which is known in humans as an X-linked autism spectrum
disorder (Derecki et al., 2012). Paving the way for therapeutic
strategies, both studies presented improvement of the respec-
tive symptoms by substitution of the defective microglia via a
transfer of wildtype bone marrow and monocytic engraftment.
In part, the data may also indicate that a genetic defect can
deteriorate theperformanceof especially someyet not allmicroglia
(Chen et al., 2010).
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Life-long consequences for the CNS and the functional behav-
ior of its microglia can also result from complications of
non-genetic nature. In this regard, intrauterine and postnatal
infections may not only impede proper development but leave
traces in form of an increased susceptibility of the CNS to sub-
sequent challenges later in life, involving altered responses of
microglia as a causative element (Bilbo et al., 2005; Stolp et al.,
2005, 2009; Bilbo and Schwarz, 2009; Monji et al., 2009), as
also discussed recently (Hanisch, 2013). Yet little is known how
exactly such early challenges of the immune defense actions of
microglia are preserved in altered properties to be conveyed to
later ontogenetic periods and whether such a priming would
occur in any or preferentially in certain cells. Specialized microglia
may, in addition, be required for the support of neurogenesis
and oligodendrogenesis, roles that have emerged more recently
(Butovsky et al., 2006b).
The principle of specialization by functions of homeostatic
maintenance seems to include the in-tissue renewal of microglia
itself. Tissue macrophages in general can maintain themselves
(Yona et al., 2013). In the absence of a pathology or experi-
mental stimuli the replenishment of microglia from extraneural
sources, such as the bone marrow and circulating monocytes, is
very low to negligible (Ajami et al., 2007, 2011; Mildner et al.,
2007). Or better to say, there is no clear evidence for any replen-
ishment during adulthood. The stability of the CNS population
must thus be guaranteed by – at least some – self-renewal, which
may depend on specialized cells with some “stem cell” attributes
(Gomez Perdiguero et al., 2013). Microglia with such a capacity
may (or even should) scatter throughout the CNS tissues, even
though some regions seem to harbor populations of a higher
proliferative potential than others (Marshall et al., 2008). In this
regard, the subventricular zone can claim a prominent status
and microglia in this niche apparently also support neurogene-
sis (Walton et al., 2006; Thored et al., 2009). Proliferation under
hoemostatic as well as pathological conditions may thus rely on
subsets rather than the entire population. Such a notion could be
supported by the assumption that a cell passing through the cell
cycle for division may not simultaneously mount a production of
cytokines, chemokines or other proteins for executive function. If
challenged by activating factors and situations that require rapid
functional responses as well as an expansion of the local cell num-
bers the affected population of microglia may split these duties by
subsets.
Increase in microglial numbers will support the capacity to
ﬁght an infection and to cope with the demands of an injured
tissue. Yet inﬂammatory inﬁltrates will also contain monocytic
cells, that present with functional heterogeneity and distinct roles
throughout the course of a disease (Butovsky et al., 2012; Lon-
don et al., 2013). They are probably needed, in addition to merely
provide more cells per se, for some functional expertise not sufﬁ-
ciently covered by resident microglia. Would dividing microglia,
on the other hand, create also offsprings with different proper-
ties or cells that are omnipotent at a more immature level? In
some aspects, microglia may also base their functional plasticity
on a kind of immaturity (Carson et al., 1998; Ladeby et al., 2005).
Furthermore,microglia canmigrate to a lesion site, experimentally
shown by an injection of a neurotoxin or by the local puncture of a
blood vessel using a laser. Areas from which they emigrated would
need some subsequent repopulation to avoid a drop in microglial
support activity. This could be achieved either by remigration or
limited proliferation – or via monocytic engraftment (Varvel et al.,
2012). Would such areas regain diversity of microglia subtypes or
just be helped by a “stopgap solution”? If constant (phagocytotic)
clearance of endogenous material is one of the important roles
of microglia in their territorial organization, understaffed tissues
could run into trouble. Phagocytic deﬁciency likely causes severe
complications (Fitzner et al., 2011; Derecki et al., 2012). On the
other hand, microglial clearance functions may have distinct and
different impacts under the various disease conditions, depend-
ing on the particular pathology as well as the phagocytic cargo
material, and with other cell populations proving sometimes more
relevant (Mildner et al., 2011). Yet homeostatic phagocytosis is still
not properly understood and would conceivably represent just one
of several house-keeping functions. The importance of synaptic
inspections may just be raised again as another example (Wake
et al., 2009).
The use of the term “heterogeneity” in direct combination
with “microglia” has thus far almost exclusively been reserved
for the different responses that are triggered when exposing cells
to a range of experimental stimuli and activating conditions, or
when dealing with the respective diversity of reactive pheno-
types in in vivo settings. Indeed, macrophages – and as more
and more appreciated also microglia – display an elaborate spec-
trum of programs for adapted gene inductions and supragenetic
organization of functions in order to react to diverse disturbances
of the tissue homeostasis. For further reading, a number of orig-
inal contributions and reviews could be suggested (Gordon and
Taylor, 2005; Martinez et al., 2006, 2013; Kono and Rock, 2008;
Mosser and Edwards, 2008; Michelucci et al., 2009; Ransohoff
and Perry, 2009; Rivest, 2009; Pollard, 2009; Biswas and Man-
tovani, 2010; Piccinini and Midwood, 2010; Pukrop et al., 2010;
Kettenmann et al., 2011; Olah et al., 2011; Saijo and Glass, 2011;
Hanisch, 2012, 2013).
DIVERSITY OF REACTIVE PHENOTYPES
Not so long ago,macrophages were underrated for the ﬂexibility in
their responses, regarding both the versatility of reactive programs
as well as the options to further adjust or shift their individual
proﬁles. This has changed drastically. Seminal discoveries and
ground-preparing achievements being done by immunological
research on (initially extraneural) macrophages resulted in reﬁned
concepts of reactive phenotype diversity (Treves, 1984; Mantovani
et al., 2004; Gordon and Taylor, 2005; Martinez et al., 2006, 2009;
Weber et al., 2007; Mosser and Edwards, 2008; van Rossum et al.,
2008; Pollard, 2009; Biswas and Mantovani, 2010; Daley et al.,
2010; Wong et al., 2010; Mikita et al., 2011; Murray and Wynn,
2011). Over the last years, this concept was rapidly implemented
in the research on microglia as well, based on diverse approaches
as well as CNS-adapted models and revealing both similarities in
principles and proﬁles – but also indicating tissue- and cell type-
speciﬁc response properties. The following references, covering
original contributions and surveys, are selected for further read-
ing (Popovich et al., 1999; Schmid et al., 2002; Town et al., 2005;
Butovsky et al., 2006c; Colton et al., 2006; Schwartz et al., 2006;
Frontiers in Cellular Neuroscience www.frontiersin.org May 2013 | Volume 7 | Article 65 | 7
“fncel-07-00065” — 2013/5/11 — 17:13 — page 8 — #8
Hanisch Microglial heterogeneity
Hanisch and Kettenmann, 2007; Ponomarev et al., 2007; Davoust
et al., 2008; van Rossum et al., 2008; Colton, 2009; Kigerl et al.,
2009; Michelucci et al., 2009; Tierney et al., 2009; Pukrop et al.,
2010; David and Kroner, 2011; Kettenmann et al., 2011; Saijo and
Glass, 2011; Olah et al., 2011, 2012; Hanisch, 2012; Starossomet al.,
2012; Zhou et al., 2012).
In its fundaments, the notion relies on the observation that
exposure to certain cytokines, such as the T helper (Th) cell
type 1 cytokine IFNγ or the pluripotent TNFα, and challenges
by microbial agents, such as LPS, other TLR-agonistic compounds
or pathogen-associatedmolecular patterns (PAMPs),would install
a “classical” activation of macrophages, that has been more or less
synonymously termed as a M1 phenotype. Such cells are defense-
oriented, release proinﬂammatory and cytotoxic factors, support
Th1 type of immune response – yet potentially and occasionally
also at the costs of damage. Th2 cytokines, like IL-4 or IL-13,
instead organize for an “alternative” activation of macrophages,
also known as M2 phenotype. The respective proﬁle is more anti-
inﬂammatory, inﬂammation-resolving. It is involved in parasite
killing and supports tissue repair. Differing from the uncom-
mitted M0 condition, the M1 and M2 phenotypes demonstrate
distinct sets of active genes. Their proﬁles are largely discrete
and partially reciprocal. By certain genes, however, they can also
overlap, rendering an isolated factor often rather inappropriate
to reliably classify the orientation. For simplicity, the reciprocal
expression of IL-10 (M2) and IL-12 (M1) served as a phenotype
indication.
Classically activated macrophages were then also reported
for an expression and/or release of TNFα, IL-1, IL-6, IL-23,
CCL2, CCL3, CCL5, reactive oxygen and nitrogen species, matrix
metalloproteinases (including MMP-1, -2, -7, -9, and -12),
cyclooxygenase 2 (COX2), iNOS, the FcR typesCD16/32/64,MHC
II and the accessory molecules B7.1/7.2 (CD80/86), that serve in
antigen presentation. Actual sets, combinations and intensities
vary with the type of macrophage and stimulus. Alternatively acti-
vated macrophages show, besides the typical IL-10, expression or
release of IL-1 receptor antagonist (IL-1ra), CCL17, CCL22, IL-
1RII, CD163, scavenger receptors, factor XIII, ﬁbronectin, COX1,
arginase 1, and enzymes for extracellular matrix (ECM) repair
(Hanisch, 2012).
The various genes and their products are not necessarily
induced under every phenotype-conform condition, as men-
tioned above. Furthermore, the M1-versus-M2 classiﬁcation does
not reﬂect the versatility – and even the kind of continuum –
of the observed spectra. IFNγ, for example, induces MHC II
in both macrophages and microglia. LPS, driving an innate or
M1-like activation, however, fails to induce it in microglia (van
Rossum et al., 2008; Scheffel et al., 2012). So, not all M1 forms
come with an congruent gene set, whereas certain gene prod-
ucts may be found in otherwise distinct phenotypes (Mantovani
et al., 2004; Edwards et al., 2006). While these variations enrich
the phenotype diversity even within the M1 domain (Starossom
et al., 2012), different types of M2 orientations were also noted
already early in these studies (Mantovani et al., 2004). Exposure
to either IL-10, antibody-antigen (immune) complexes or their
combinations with TLR and other agonists, contact to cellular
breakdown material along with its phagocytotic removal, contact
to apoptotic cells or association with a tumor install phenotypes
that share M2 likeness, while simultaneously displaying sufﬁcient
differences to allow for subclassiﬁcation as to M2a, M2b, and
M2c. Consequently, not isolated markers but proﬁles deﬁne the
actual state of the cells, while stages in a response process, lack of
typically indicative or concomitant expression of “opposite”mark-
ers may hamper simple deﬁnitions and blur phenotype borders
(Gerber and Mosser, 2001; Anderson and Mosser, 2002; Ander-
son et al., 2002; Town et al., 2005; Edwards et al., 2006; Mosser
and Edwards, 2008; van Rossum et al., 2008; Kettenmann et al.,
2011). The dynamic nature of responses cannot be emphasized
enough (London et al., 2013). Monocytes/macrophages likely dis-
play distinct molecular signatures as they correlate with distinct
activities and functions during the initiation, progression and
resolution of a disease and the reaction to it. In addition, phe-
notype inductions in microglia and extraneural macrophages
by standard stimuli, such as LPS, IFNγ, or IL-4, can lead to
similar yet discrete proﬁles of induced genes and functional con-
sequences (Butovsky et al., 2006c; van Rossum et al., 2008; Girard
et al., 2013), as previously discussed (Kettenmann et al., 2011;
Hanisch, 2012, 2013).
New candidate proteins and carbohydrate moieties allow now
a fairly reliable association with reactive phenotypes as to their
bifurcated polarity or their distinguishable varieties. To name
a few, claudin (Cldn) 1, 2, and 11, found in inﬂammatory
zone 1 (FIZZ1), mouse macrophage galactose-type C-type lectins
(mMGL) 1 and 2, sphingosine kinase-1, TNF superfamilymember
14 (LIGHT), transglutaminase 2, the secretory lectin chitinase 3-
like protein 3 Ym1 or O- and N-glycans sort with M1 and M2
orientations, although functions in general and in regard to the
phenotype are often unclear (Chang et al., 2001; Raes et al., 2002,
2005; Colton et al., 2006; Edwards et al., 2006; Maresz et al., 2008;
Starossom et al., 2012; Van den Bossche et al., 2012; Zhou et al.,
2012; Martinez et al., 2013).
It is important to note – also for our discussion on hetero-
geneity – that phenotypes are chosen at the beginning of the
activation process, based on initial sets of information on threat-
ening events. Gene expression may subsequently shift, organized
by cell-autonomous mechanisms (taking late induction of IL-10
as an example), or due to altered conditions (e.g., when primary
stimuli fade upon successful clearance, as for microbes) or with
modulatory factors gaining inﬂuence (like cytokines, resolvins,
and other mediators that are emitted by inﬁltrating neutrophils,
monocytes, or T cell populations). Reactions may start with a
defense orientation that later on deescalates and fades when pro-
ﬁles are required that facilitate structural repair and functional
restoration. In the living tissue, phenotypes ideally induced in
experimental settings as of M1- or M2-like blends could proba-
bly develop as transient stages of a complete response. We have
discussed these issues in recent reviews (Kettenmann et al., 2011;
Hanisch, 2012).
Notebaly, macrophages do not only commit to diverse pheno-
types upon deﬁned challenges. More or less pronounced overlaps
between functionally relatedproﬁles could (and actually do) exist –
especially in the more complex in vivo situations – as many genes,
including those with an “inﬂammatory connotation,” are impor-
tant in several responses to (as well as following to) infection and
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injury. Phagocytotic activity and proinﬂammatory components
are needed for wound healing and repair. On the contrary, inﬂam-
mation is a double-edged sword in cancer development and pro-
gression. It can even be supportive, and macrophages can display a
bewildering variety of phenotypic markers and their combination
in tumor association, as they do in many other disease situations,
such as in atherosclerosis, or repair (Mantovani et al., 2004; Man-
tovani et al., 2009; Pukrop et al., 2010; Mantovani et al., 2013).
They can exhibit phenotypic proﬁles that do not easily sort by a
strict M1/M2 dichotomy. Also microglial populations can present
with more complex locotemporal patterns of their morphological,
molecular and functional features (Kigerl et al., 2009; Morrison
and Filosa, 2013). Evidence for the parallel existence of M1- and
M2-oriented cells in a mouse spinal cord injury model either
points to hybrid states expressing genes of either activation type or
suggests discrete cellular subsets following own time courses and
having independently organized programs (Kigerl et al., 2009).
Orientations could be split between the resident microglia on
one and inﬁltrating monocytes on the other side – or the lines
of demarcation are not that simply drawn by CNS-intrinsic versus
extraneural origin. While it is obviously not a trivial task to assign
a certain reactive phenotype as a dominat as well as persisting
response pattern of macrophages and microglia to a given pathol-
ogy, in some cases amajor orientation and the respectivemolecular
and cellular mechanisms can be successfully linked to a disease
(Heneka et al., 2013).
RESPONSE HETEROGENEITY UPON CHALLENGES
An increasing number of already characterized (and probably
still to be identiﬁed) factors of exogenous (microbial), endoge-
nous and especially CNS-intrinsic (homeostatic and damage-
or degeneration-related) factors takes inﬂuences on the activity
state and activity recruitment of microglia, as listed previously
(Hanisch, 2002; Hanisch and Kettenmann, 2007; Kettenmann
et al., 2011; Hanisch, 2012, 2013). They differ by origin and
the situations in which they appear in microglia activation-
relevant concentration and format, they belong to most dis-
parate classes as to their chemical structure, they employ diverse
modes of action and they deﬁnitely vary by their phenotype
instructions.
As a principle to set an alert and to trigger a rapid transition
from the surveillance (“resting”) mode to executive states, sig-
nals appear in the form of receptor agonists that are normally not
found in the microglial environment – not at all, not with rel-
evant modiﬁcation or arrangement (e.g., oxidized or aggregated
forms) or at effective concentration. Many classes of compounds
that play roles in microglial instructions for phenotypic commit-
ments follow this principe of “on signaling,” in which already
expressed surface or intracellular receptors are stimulated by
the arrival of their cognate ligands (Hanisch and Kettenmann,
2007; Kettenmann et al., 2011; Hanisch, 2012). Major exam-
ples relate to cytokines. Typically, “on signaling” occurs with
the assortment of evolutionary conserved structural motifs in
glyproteins, lipopeptides, glycolipids, RNA, and DNA of virus,
bacteria, fungi, and protozoans, commonly described as PAMPs,
which are sensed by germ line-encoded pattern recognition recep-
tors (PRRs), notably NOD-like receptors (NLRs), RIG-I-like
receptors (RLRs), C-type lectin receptors (CLRs), absence in
melanoma 2-like receptors and TLRs (Kawai and Akira, 2010;
Takeuchi and Akira, 2010).
In other situations, when damage or impairment has to be
sensed by microglia in the absence of infection, endogenous
factors can act as “activators” to drive an innate immune reac-
tion as a sterile inﬂammation (Chen and Nunez, 2010; Stewart
et al., 2010). Classiﬁed as damage- or danger-associated molec-
ular patterns (DAMPs), these disparate molecules (mainly but
not only proteins) usually serve most diverse functions and
gain the role as danger signs only upon unphysiological release
(from a cell), translocation (from the plasma to the parenchyma)
and modiﬁcation (e.g., oxidation; Rubartelli and Lotze, 2007;
Lotze et al., 2007; Kono and Rock, 2008; Zhang and Mosser,
2008; Piccinini and Midwood, 2010). DAMP activities have been
established for (to name a few) chromatin-associated and other
intracellular proteins, such as high mobilioty group box pro-
tein (HMGB) 1, S100A8, and S100A9, a range of heat shock
proteins, ECM and plasma components, such as tenascin, ver-
sican, ﬁbronectin, lactoferrin, lipoprotein A, and oxidized low
density lipoprotein, but also serum amyloid and amyloid β (Aβ;
Hanisch, 2012). New entries to the list are reported on a con-
stant basis, recently regarding fetuin (Pal et al., 2012). Interestingly,
many of these DAMPs are recognized by the binding to PAMP
receptors, most notably TLRs. By the recognition of alarming
structural patterns a rather small number of such receptors can
cover a wide range of pathogens as well as indicators of dangerous
situations – and the reactions to these threats would be immedi-
ately in the hands of the sentinel cells, like microglia in the CNS
(Hanisch, 2012, 2013).
In contrast to this “on signaling,” microglia can, in turn, also
be alerted and “activated”when certain calming inﬂuences fade or
disappear. Accordingly, such an organization would be a kind of
“off signaling,” the term being introduced as a microglial principle
already in 2004 (van Rossum and Hanisch, 2004; Biber et al., 2007;
Hanisch and Kettenmann, 2007; Hanisch, 2012). For ﬁrst pairs of
ligands and their receptors, reciprocal expression by neurons and
microglia has been shown to have a controlling inﬂuence, such as
in the cases of CD200/CD200R, CD47-SIRPα, CX3CL1/CX3CR1
and CD22/CD45. Yet microglia may sense the decline of neigh-
boring neurons also via altered neurotransmitter levels. Both
sources of information could be important formicroglia to rapidly
respond to any homeostatic disturbance affecting neurons simply
on the basis of lost inputs, and without the need of express-
ing a sweeping array of particular receptors (Hanisch, 2013).
In other words, danger is recognized, also by microglia, via a
whole tool box of receptors and signaling systems (Lotze et al.,
2007; Matzinger, 2007; Rubartelli and Lotze, 2007; Lehnardt et al.,
2008; Kettenmann et al., 2011). In harsh contrast to the growing
knowledge on signals and signaling principles that keep the con-
trol over microglia as a major cell type in the CNS, much less
information is yet delivered as to the individuality of the cellular
responses.
Injections of LPS into rat neocortex, hippocampus or the sub-
stantia nigra revealed a markedly distinct susceptibility in terms of
neurodegeneration,with aprofound impact onmesencephalic and
especially dopaminergic neurons (Kim et al., 2000). The critical
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role of microglia was addressed in respective neuron-glia culture
preparations. Sensitivity of mesencephalic and resistance of cor-
tical and hippocampal neurons both in vivo as well as in vitro
apparently matched the region-selective microglial responsiveness
and responses. The substantia nigra is the CNS region in rodents
that accommodates the highest density of microglia (Lawson et al.,
1990). Respective cell transfer (supplementation) experiments
could associate cell number and outcome. Yet quantity might not
explain all regional differences. Neonatal rat microglia isolated
form brainstem, cortex, hippocampus, striatum, and thalmus dif-
ferently responded to glutamate, ATP and LPS (Lai et al., 2011).
This report and other work with functional demonstrations (van
Weering et al., 2010) correlate to the inventories of distinct expres-
sion proﬁles (de Haas et al., 2008) and precipitate the conclusion
as to region-speciﬁc microglial populations. Of course, the onto-
genetic stage of the microglial sample cannot be neglected since
several features, especially the organization of receptor signaling
and stimulation consequences, obviously mature not only prior
but also after birth (Draheim et al., 1999; Scheffel et al., 2012).
Nevertheless, regional distinction with varying resolution is on
the way to depict responder heterogeneity in rather circumscribed
areas.
In a recent study, we addressed the postnatal reorganization
of microglial responses to TLR activation (Scheffel et al., 2012).
Along the characterization of inducible genes and proﬁles of syn-
thesized factors we also observed responder subsets, i.e., cells being
responsible for the release of certain cytokines and chemokines.
The respective distinction of producers from the non-producing
subpopulations developed as part of a more general maturation
of microglial features. This concerned proﬁles of genes and activ-
ities expressed under basal conditions or subsequent to a deﬁned
stimulation. Microglia were harvested from mice at birth or at the
postnatal days P21 and P49 and kept ex vivo for various periods
of time. Interestingly, and against the common expectation, sev-
eral features that were studied in repeated sessions did not reveal
obvious changes with the time in culture but differed, partially in
a drastic fashion, with the time point during postnatal develop-
ment, namely the day at which the microglia were isolated. Even
though such an ex vivo approach would never claim to properly
reﬂect tissue-encoded features of the cells in their entire com-
plexity, at least some of the critical aspects seemed to be carried
over to the culture where they were maintained with surprising
stability.
Whenmicrogliawas challengedwith deﬁned structural varianst
of LPS they produced, among other cytokines and chemokines,
TNFα (Regen et al., 2011; Scheffel et al., 2012). Microglia could
even discriminate among the LPS chemotypes as to the actual
release proﬁles, and this ability developed postnatally. Notably,
synthesis of TNFα related to a subpopulation which increased
from about 30% in neonatal to 75% in the young adult cells.
At the same time, the boundaries deﬁning the responder versus
non-responder subpopulations – as revealed in ﬂow cytometry
– gained precision (i.e., by increased peak distance). Moreover,
the two subtypes were then also seen in isolates of microglia
from different regions of the adult CNS (Scheffel et al., 2012).
Their existence was conﬁrmed by immunocytochemistry on both
cells and organotypic brain slice preparations in vitro (using also
confocalmicroscopy) and on tissue sections frommice that under-
went targeted focal experimental autoimmune encephalomyelitis
(EAE).
Selective induction of TNFα was accompanied by a subset-
restricted synthesis of CCL3, an important chemokine also known
as macrophage inﬂammatory protein 1α (MIP-1α), that serves in
the attraction of monocytes, T and B cells, eosinophils as well
as DCs (Scheffel et al., 2012). The rather small subpopulation
would apparently sufﬁce an impressive release, since CCL3 can
be induced in high amounts. Most of the CCL3-synthesizing cells
were contained in the (larger) population of TNFα producers, as
revealed by combined detection. This TNFα+CCL3+ subpopula-
tion increased in size as the postnatal development of microglia
features proceeded – ascertained by expression and cell cycle anal-
yses as well as electrophysiological recordings (Scheffel et al., 2012;
Hanisch, 2013).
In support of these observations, a similar subset-selective
TNFα induction by LPS was also reported for rat microglia
(Kawahara et al., 2009; Shen et al., 2009), ruling out a species
phenomenon. Employing FluoroSpot technology for single cell
analyses among populations, a comprehensive characterization of
TLR-activated cytokine secretion recently revealeddistinct respon-
der subtypes among human monocytes (Smedman et al., 2011).
Production of TNFα was determined in subpopulations of TLR2-
and TLR4-stimulated cells. Moreover, also other cytokines and
chemokines depended for their release on subsets. Interestingly,
combinatory detections identiﬁed cells with co-secretion capacity
for pairs of factors, such as TNFα and MIP-1β (CCL4), whereas
fractions of cells in the same population revealed only singular
synthesis. Moreover, the release of certain cytokines relied on
surprisingly small numbers of cells. IL-12p40 production, for
example, was conﬁned to less than 10% of the monocytes. Find-
ings of this study – focusing on human monocytes – are thus very
similar to those obtained with rodent microglia.
While a developmental reorganization of the microglial TLR
systems is also in line with the data by others (Kaul et al., 2012),
our ﬁndings point to a rearrangement in the associated signaling
cascades, rather than a change in receptor expression. Evidence
indicates an altered organization of the pathway requiring the
signaling adaptor myeloid differentiation primary response gene
88 (MyD88), which participates in intracellular consequences of
almost all TLRs (except for TLR3). On the contrary, the adaptor
protein TIR-domain containing adaptor protein inducing IFNβ
(TRIF), that conveys information under TLR3 and also for TLR4,
seemd to be spared. Noteworthy, we found critical TLR4 func-
tions to be distinctly governed by MyD88 and TRIF (Regen et al.,
2011) and to undergo transient reorganization during postnatal
development (Scheffel et al., 2012). Exempliﬁed for the reactions
to TLR1/2, TLR4, and TLR6/2, microglia rebuild their mecha-
nisms during a critical window within the ﬁrst few weeks after
birth (marked by a peak around p21) – while simultaneously pass-
ing through a gradual change of other properties. Microglia will
acquire the typical morphology of the “resting” cell (which is not
dormant, as we know), accompanying the maturation of the CNS
in terms of its neuronal circuitry and myelination (Scheffel et al.,
2012). As this period coincides with a suggested phase of increased
susceptibility toCNS infection,we also testedmice for the outcome
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of an intracerebral bacteria deposition and noticed a higher mor-
tality for those at P21, in comparison to animals at an age
of P49.
The formation of TNFα- and CCL3-producing subsets of
microglia under LPS was not related to a lack of TLR(4) in the
complementary cell fraction. When studying microglial induc-
tions upon TLR4 challenge, we found a strong expression of MHC
I in almost all cells. While failing to induce MHC II under these
conditions, LPS caused a panpopulational response in microglia
at any age and in all regions examined (Scheffel et al., 2012). MHC
I+TNFα− andMHC I+TNFα+ microglia thus do not split by their
TLR4 expression and responsiveness as such. Among the TLRs,
TLR4 appears to be homogeneously distributed over macrophage
populations (Gautier et al., 2012). In the case of microglia, cells
must rather differ by TLR4 signaling. Under the inﬂuence of
TLR4-agonistic PAMPs or DAMPs, subsets could provide individ-
ual elements to compose the reactive phenotype of a responding
microglia population. Some deliver, for example, TNFα to which
other cells have then to obey, while all of them identify them-
selveswithMHC I expression. Sincemicroglia differ by their TNFα
receptor expression (Kraft et al., 2009), this could create a hierar-
chy of cells, with some in control of the synthesis and others with
a varying level of perception. Cells with preferential expression of
enzymes, such as COX2 or iNOS, could similarly serve as (privi-
leged) sources of prostaglandines and NO (Kawahara et al., 2009;
Scheffel et al., 2012). Reactive phenotypes may thus reﬂect an
ensemble of individual cellular engagements. Inhomogeneous
responses of microglia in circumscribed populations (i.e., of
a deﬁned tissue region) to a homogeneously presented stimu-
lus could be taken as a hint to their differential organization.
Distinct response capacities could be established even before
the challenge. Heterogeneity could be, at least in some part, a
constitutive one.
In contrast to MHC I, microglial expression of MHC II for
professional antigen presentation was not triggered by TLR4 acti-
vation, but readily induced by IFNγ, both in vitro as well as in
vivo, and then in a subset (Fitzner et al., 2011; Scheffel et al.,
2012). Also upon injection of IFNγ in vivo, microglia reveal
MHC II immunoreactivity (Fitzner et al., 2011). B7.1 and B7.2
(CD80 and CD86), costimulatory molecules for MHC II func-
tion and interaction with CD4+ T cells, also revealed induction
by subsets. IFNγ injection in animals caused a scattered MHC
II+ induction, a pattern ruling out that it just followed a gradi-
ent (Fitzner et al., 2011; Scheffel et al., 2012). Moreover, evidence
for restricted expression can also be derived from other reports
(Ponomarev et al., 2005, 2006; Starossom et al., 2012). We pre-
sented data from a histopathological examination of human tissue
that expression of respective HLA structures in hypoxic lesions
is conﬁned to individual microglia (Scheffel et al., 2012). TLR4
signaling organization by subsets could probably relate to the
organization of subsets by MHC II expression. A recent study
identiﬁed a previously unknown importance of the intracellu-
lar MHC II pool in acting as an adaptor in TLR signaling (Liu
et al., 2011). Conceivably, MHC II, as it is also inducible by
IFNγ, would then participate in the TLR reactions of some cells,
whereas TLR4 itself is functionally expressed by the majority
of microglia. The well-known phenomenon of IFNγ priming
as affecting microglial challenges by LPS (Häusler et al., 2002)
may consequently involve unequal mechanisms in cellular subsets
(Scheffel et al., 2012).
While phagocytotic and other clearance mechanisms are essen-
tial elements of the microglial activity spectrum to support
CNS development as well as maintenance, removal of foreign
and endogenous material is most critical in infections, injuries,
autoimmune and degenerative processes (Hanisch and Ketten-
mann, 2007; Kettenmann et al., 2011). Successful clearance of
bacteria decides already in the initial phase of an infection on
the extent of damage and sequelae, while efﬁcient removal of
myelin debris is a known prerequisite for attempts of remyeli-
nation in multiple sclerosis. In other disease, deﬁciency in the
clearance of protein deposits, such as Aβ plaques in Alzheimer’s
disease, may have harmful outcomes, with the role of microglia
being different in comparison to extraneural monocytes. Mecha-
nisms of a functional – and dysfunctional – clearance are of an
imaginable huge clinical importance (see also above). On the
other hand, these functions have been addresses mainly for the
microglia, with thus far little conscious distinction of potential
subtypes.
Myelin uptake activity in pathophysiological conditions appar-
ently associates with a fraction of microglia (van Rossum et al.,
2008; Regen et al., 2011; Scheffel et al., 2012), similarly as
it was described for the physiological disposal of exosomally
encapsulated myelin (Fitzner et al., 2011). Even though the under-
lying mechanisms and the responsible molecular machinery of
incorporationwill differ between clearances of the exosomes versus
free myelin, both are suppressed by inﬂammatory conditions (van
Rossum et al., 2008; Fitzner et al., 2011; Regen et al., 2011; Schef-
fel et al., 2012). Interestingly, TLR activity regulates the myelin
clearance with MyD88 signaling dependence and with opposite
outcome in comparison to the phagocytosis and killing of Gram-
negative as well as -positive bacterial strains (Ribes et al., 2009,
2010a,b, Ribes et al., 2011). The latter functions might also be
reserved for subtypes, as work in progress suggests. Probably,
this qualiﬁes only partially overlapping sets of microglia as spe-
cialists that are either called up for duty when the CNS is under
an infectious attack or take the part of clearing the terrain from
debris.
The collecton of evidence for microglial responder heterogene-
ity could be continued as the literature can serve as a source
for data and images that contain such information, although
explicit mentioning is not always found in the text. Of course,
gene expression studies reveal signatures that apply to microglia
as a CNS-resident entity. Microglia show low expression of many
transcripts which are readily found in extraneural macrophages,
whereas they present with a particular proﬁle of other genes, such
as those encoding formolecules of the oxidativemetabolism (Gau-
tier et al., 2012). While such classes will be used to understand
the gross-anatomical organization of myeloid cell distribution
and function, it will be the identiﬁcation of also minute differ-
ences that could provide an image of microglial response diversity
and its probably underlying constitutive heterogeneity at high
resolution. There is a list of molecules and activities, responses
as well as susceptibilities with particular expression and distri-
bution patterns, which would deserve consideration for subset
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analyses (Butovsky et al., 2006a; He et al., 2006; Sriram et al., 2006;
Ensinger et al., 2010; Iwama et al., 2011). Some molecules, such
as galectin-3/Mac-2, could thereby prove as suitable candidates
for delineating sets of cells by expression and associated function
(Venkatesan et al., 2010).
INSTRUCTION AND ORGANIZATION OF
HETEROGENEITY
Since the concept of microglial heterogeneity is just emerging,
potential principles of its organization are still enigmatic. Several
sources of instruction can, however, be envisaged. One may deﬁne
orientations of cells during development. Alternatively, cells may
acquire their individuality upon arrival at their tissue destination
andwithin the respective local cell community. Still anothermodel
could be based on probability.
HETEROGENEITY BY LINEAGE ORIGIN AND MICROENVIRONMENT
Substantial efforts based on genetic strategies and fate mapping
have led to the identiﬁcation of progenitors and lineages that
give rise to the various myeloid cell types and thereby cover-
ing macrophages of various tissues, including microglia. Against
the common believe of a mandatory monocytic replenishment,
this work can strengthen concepts claiming primitive progeni-
tors from the yolk sac as a source. It shows that major tissue
macrophage populations are established before birth and kept
independent of monocytes from the blood (Naito et al., 1996;
Yona et al., 2013). Transcription factors have been nominated to
be distinctly involved in the development of DCs, monocytes, tis-
sue macrophages and microglia, such as Batf3, Flt3, PU.1, or Myb
(Ginhoux et al., 2010; Gautier et al., 2012; Schulz et al., 2012; Sat-
pathy et al., 2012; Gomez Perdiguero et al., 2013). Work published
now adds factors and steps for microgliogenesis, conﬁrming PU.1
and introducing Irf8 (Kierdorf et al., 2013). Accordingly,microglia
derive from primitive c-Kit-positive erythromyeloid precursors in
the yolk sac of themouse that develope through stageswith distinct
expression patterns of CD31, CD45, c-Kit, CX3CR1, F4/80 as well
asMCSFRand that depend for proper development and settlement
also on MMP-8 and MMP-9 (Kierdorf et al., 2013). This fascinat-
ing research will continue to ﬁll gaps in precursor sequences and
help to draw road maps of tissue population (colonization). Con-
ceivably, some late differentiation steps include further splitting of
the microglial lineage to create diversity by subsets. Earlier work
suggested, based on a gene defect and respective lineage label-
ing, that not the entire microglia population was affected, leaving
room for speculation as to its heterogeneity (Chen et al., 2010). If
microglial lineage branching during development would give rise
to subtypes their distribution throughout the CNS would need
to be outlined as well – especially to explain their settlement in
overlapping territories.
Alternatively to a predisposition of cells as to their origin,
tissue adaptation of molecular and functional properties could
derive from local instructions and the requirements of partic-
ular micromilieus. The anatomical divisions of the CNS come
with variable composition as it regards their cellular and molec-
ular constituents. Simply sorted by white and gray matter, the
regions differ by the content of myelin, a complex and vulnera-
ble structure that by itself may determine microglial properties
or set directions for the ﬂow of messengers. Expression of recep-
tors does vary by region, and inspection of data published earlier
may indicate trends by white matter content (de Haas et al.,
2008). These differences could impact on development, normal
functionality or the vulnerability of CNS structures to inﬂam-
mation (McKay et al., 2007; Hristova et al., 2010). Microglia
from white and gray matter differ by expression of Tim-3, an
immunoregulatory receptor (Anderson et al., 2007). The authors
linked its differential and timed expression by microglia, DC-
like as well as Th1 cells to a regulation of inﬂammation and
immune responses in deﬁned phases. Interestingly, heterogene-
ity of microglia might be complemented by heterogeneity of
oligodendroglial subpopulations in subregions of gray and white
matter (Kitada and Rowitch, 2006). The biochemical milieu
is also determined by the vascular and ECM features. Expo-
sure to some plasma factors at certain sites – and not only
upon a BBB disruption – may affect neighboring microglia, as
reﬂected by the distinct sialoadhesion expression (Perry et al.,
1992). Microglia are not just embedded in an ECM environment
for structural support. Interactions are not limited to the manip-
ulation and rebuilding of ECM by microglial proteases, such as
upon an injury or cell migration, but include signals to microglia,
for example via integrins. Certain factors are – in varied for-
mat – present in both the plasma and the ECM, like ﬁbronectin,
that can potentially trigger microglial responses through TLR4
(Regen et al., 2011).
Structures of the CNS vary by prevalent neurotransmitters, for
example in the cerebral cortex by the layers. Microglia express a
range of classical neurotransmitter and purinergic receptors and
also respond to their activation (Pocock and Kettenmann, 2007).
Accordingly, they may sense acetylcholine, dopamine, glutamate,
noradrenaline, GABA, and purines, namely ATP and metabolites
(Kettenmann et al., 2011). In addition, the repertoire of recep-
tors covers those for neurohormones, neuromodulators, steroids,
prostaglandins, leukotrienes, complement, and immunoglobulins
in order to respond by various outcomes to opiodis, angiotensin,
bradykinin, endothelin, neurokinins, neurotrophins, somato-
statin, vasoactive intestinal polypeptide, cannabinoids, histamine,
platelet activating factor, glucocorticoids, and mineralocorticoids
(Kettenmann et al., 2011). Microglia have been shown to express
receptors for proteases, such as thrombin, which may come into
play when an injury causes inundation of the parenchyma by
plasma content but also when such factors are operating within
the intact CNS (Balcaitis et al., 2003; Hanisch et al., 2004). Their
importance may differ and vary with the ontogenic stage or
homoeostatic situation. Some may serve as modulators to syner-
gize with or to contain the consequences of cytokines, chemokines
or microbial agents (Kettenmann et al., 2011). Undoubted is, how-
ever, that they would exert control on different microglial cell
populations differently depending on the local levels of their ago-
nists. Distinguishable expression proﬁles of such receptors would
determine distinct functional adjustments. Yet even more classical
neurotransmitter receptors may have some not yet fully appreci-
ated implications in a general, phasic or disease-related control
of microglia and with speciﬁcity by receptor properties and out-
comes by region (Zerrate et al., 2007; Heneka et al., 2010). For CNS
tissue structures and their microglia, neurochemical cues could be
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critical determinants. However, would tiny differences or ﬂat gra-
dients of instructing factors be sufﬁcient to govern differential
subtype orientation for cells in close vicinity?
RESPONDER SUBTYPES BY STOCHASTIC VARIATION
The above mechanisms would deﬁne individual capacities of
microglia by some constitutive principle. Cells would be pre-
determined by lineage commitment or by their environment. Yet
variety in responses, such as proﬁles of induced genes, could also
be explained by probability (Hume, 2000). This exciting con-
cept describes transcriptional regulation in individual cells by
probabilistic events and could explain heterogeneous expression
among a cell population as occurring by chance. The concept
explicitly applies to leukocyte differentiation and activities. It
thereby even offers tempting options for explaining the obser-
vation of subpopulations. Key to the model is the variable stability
of the respective mRNAs and their translation products, i.e.,
proteins. A physiological “purpose” of such a simply stochas-
tic organization could derive from the generation of an entire
spectrum of individual responses in individual responders. Such
a repertoire could then cope with any challenge. Indeed, het-
erogeneity in the responses of a macrophage cell line to LPS
exposurewas subsequently shown to arise fromautonomousprob-
ability in the transcription of individual genes, including TNFα
(Ravasi et al., 2002).
A “hatched” expression of genes could be an argument against
the existence of “real,” namely pre-determined subtypes. In sub-
population analyses of any kind, some quantitative variation could
pretend qualitative distinctions simply due to insufﬁcient detec-
tion sensitivity or a variation by chance. The former situation
would be a technical pitfall, the latter would stand for a basic
phenomenon. A probabilistic organization of response diversity
would thus not require any pre-instruction and leave the decision
on subtypes to the moment of a challenge. It remains to be shown
whether this is enough to explain all facets of functional diversity of
microglia (and other myeloid cell populations), including house-
keeping activities and activation in emergency settings. Indeed,
transcriptional regulation in macrophages presents with some
previously unforeseen complexity (Lawrence and Natoli, 2011).
Multiplicity of approaches will avoid that conclusions are rashly
drawn from single lines of evidence. In this regard, populational
context may determine single-cell heterogeneity in a combina-
tion of intrinsic and extrinsic factors. Modeling approaches aim
at explaining the phenomenon and to predict differences among
a cell population with regard to gene transcription, phospho-
rylation events, cell morphology as well as drug perturbations
(Snijder et al., 2009). Stochastic ﬂuctuations in transcription fac-
tors at critical decision-makingphases couldparticipate in creating
and determining (also local) diversity of microglia. Most con-
vincing support for an existence of distinct microglia could be
taken from a demonstration of the vital importance of a par-
ticular subtype and by dissecting the mechanisms by which it is
instructed.
ADJUSTMENT OF RESPONSE CAPACITIES BY EXPERIENCE
All this has to consider that microglia are a rather long-lived pop-
ulation that is probably maintained with some in-tissue renewal
but – most likely – without replenishment from bone mar-
row sources, at least under healthy adult conditions (Mildner
et al., 2007; Ajami et al., 2011; Gomez Perdiguero et al., 2013).
If instructed for a set of (potential) functions by local cues, the
setting might be either constantly maintained, similarly driven
by receptor signaling as it was discussed for control of the activ-
ity level by “on” and “off” signals, or it might be induced once
and preserved. Could a microglia subpopulation, for exam-
ple, be experimentally translocated from its natural location to
another tissue region and thereby change prominent features? It
would also be important to clarify whether commitments stay
stable throughout the life span of the individual cell and/or
whether they may change – especially also following to a chal-
lenge. Would, for example, a transient activation episod simply
lead to a return of microglia to their naïve pre-activation sta-
tus or leave an engram affecting functional behavior in the
post-activation phase? Would this lead to a (locally) distinct
microglia?
This question has been raised but awaits further answers
from experimental demonstrations of either preserved or altered
microglial properties subsequent to activation (Hanisch and Ket-
tenmann,2007; Saijo andGlass, 2011; Hanisch, 2012). Phenomena
of “priming” and “tolerance,” however, are already described. Also
microglia change responses to a stimulus after being exposed
to the same or another stimulus before (Häusler et al., 2002).
If lasting for a longer period of time, such an altered pheno-
type setting could be termed “experience” or even “memory.”
Traces of former gene activation remain in form of epigenetic
modiﬁcations and thereby affect transcriptional activity for a
long time and even through a cell cycle (Probst et al., 2009;
Suderman et al., 2012). Covalent modiﬁcations of chromatin
proteins or the DNA itself are major epigenetic principles. In
contrast to cells of the adaptive immunity (such as T lym-
phocytes), which reveal distinct epigenetic changes during their
differentiation (Wei et al., 2009), epigenetic regulation in innate
immune cells is still largely unknown. As macrophages maintain
a high degree of plasticity to commit to diverse reactive pheno-
types, epigenetic modiﬁcations could be expected to take a part
therein. Indeed, regulations of this kind seem to play fundamen-
tal roles in inﬂammatory processes and the functional control
of innate immunity (Foster et al., 2007; Foster and Medzhitov,
2009).
CONCLUSION
After all, the plural term “microglia” may include a true mean-
ing as to the existence of subsets with preferential or exclusive
duties. Subsets may specialize for day-to-day functions as well
as harbor selective capacities that become effective on demand.
Whether such an individuality is predestined before or orga-
nized upon arrival of microglia at their locations in the tissue
– or whether it occurs upon challenge as an entirely stochas-
tic phenomenon – still remains to be shown. Whether and
how a specialization can be found similarly throughout the
CNS is not known either. The concept of functional diversity
is worth more consideration not for the sake of an inven-
tory of modiﬁcations or a sorting of cells and cell activities
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of every description. Practical value derives from a reﬁned clas-
siﬁcation of activities and activity states in lesions or during
the course of a neuropathology. Most importantly, individual
microglial subsets and (or) their functions could be addressed by
targeted manipulation in experimental settings and therapeutic
interventions.
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